IDEX Biometrics ASA (FRA:I8X) Cyclically Adjusted Revenue per Share: €0.76 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:I8X IDEX Biometrics ASA FRA:I8X
25 GF Score
Price €0.75
GF Value €0.05
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is IDEX Biometrics ASA Cyclically Adjusted Revenue per Share?

IDEX Biometrics ASA FRA:I8X -0.27% 25 Cyclically Adjusted Revenue per Share is €0.76 as of Mar. 2026. GuruFocus rates FRA:I8X with a GF Score™ of 25/100 and a GF Value™ of €0.05 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

IDEX Biometrics ASA's adjusted revenue per share for the three months ended in Mar. 2026 was €0.002. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.76 for the trailing ten years ended in Mar. 2026.

During the past 12 months, IDEX Biometrics ASA's average Cyclically Adjusted Revenue Growth Rate was 3.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 16.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of IDEX Biometrics ASA was 24.50% per year. The lowest was -7.00% per year. And the median was 12.75% per year.

As of today (2026-08-04), IDEX Biometrics ASA's current stock price is €0.75. IDEX Biometrics ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €0.76. IDEX Biometrics ASA's Cyclically Adjusted PS Ratio of today is 0.99.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IDEX Biometrics ASA was 448.54. The lowest was 0.33. And the median was 84.19.


IDEX Biometrics ASA  (FRA:I8X) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

IDEX Biometrics ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.75/0.76
=0.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IDEX Biometrics ASA was 448.54. The lowest was 0.33. And the median was 84.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


IDEX Biometrics ASA Cyclically Adjusted Revenue per Share Related Terms


IDEX Biometrics ASA Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for IDEX Biometrics ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEX Biometrics ASA Cyclically Adjusted Revenue per Share Chart

IDEX Biometrics ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.45 0.55 0.68 0.76

IDEX Biometrics ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.52 0.00 0.76 0.76

FRA:I8X vs QH, SHOP, UBER: Cyclically Adjusted Revenue per Share Comparison

For the Software - Application subindustry, IDEX Biometrics ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEX Biometrics ASA Cyclically Adjusted PS Ratio vs Software Industry

For the Software industry and Technology sector, IDEX Biometrics ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IDEX Biometrics ASA's Cyclically Adjusted PS Ratio falls into.


FRA:I8X
25GF Score
IDEX Biometrics ASA FRA:I8X
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEX Biometrics ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IDEX Biometrics ASA's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.002/141.0300*141.0300
=0.002

Current CPI (Mar. 2026) = 141.0300.

IDEX Biometrics ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.769 103.800 1.045
201609 0.436 104.200 0.590
201612 0.646 104.400 0.873
201703 0.338 105.000 0.454
201706 0.229 105.800 0.305
201709 0.178 105.900 0.237
201712 0.058 106.100 0.077
201803 0.022 107.300 0.029
201806 0.014 108.500 0.018
201809 0.051 109.500 0.066
201812 0.095 109.800 0.122
201903 0.004 110.400 0.005
201906 0.016 110.600 0.020
201909 0.046 111.100 0.058
201912 0.022 111.300 0.028
202003 0.033 111.200 0.042
202006 0.053 112.100 0.067
202009 0.081 112.900 0.101
202012 0.137 112.900 0.171
202103 0.149 114.600 0.183
202106 0.206 115.300 0.252
202109 0.214 117.500 0.257
202112 0.174 118.900 0.206
202203 0.215 119.800 0.253
202206 0.309 122.600 0.355
202209 0.282 125.600 0.317
202212 0.836 125.900 0.936
202303 0.248 127.600 0.274
202306 0.265 130.400 0.287
202309 0.203 129.800 0.221
202312 0.094 131.900 0.101
202403 0.049 132.600 0.052
202406 0.129 133.800 0.136
202409 0.017 133.700 0.018
202412 0.004 134.800 0.004
202503 0.007 136.100 0.007
202506 0.002 137.800 0.002
202509 0.000 138.500 0.000
202512 0.001 139.100 0.001
202603 0.002 141.030 0.002

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.76 mean?
IDEX Biometrics ASA (FRA:I8X) has a Cyclically Adjusted Revenue per Share of €0.76 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IDEX Biometrics ASA and its competitors.
Is IDEX Biometrics ASA's Cyclically Adjusted Revenue per Share too high?
IDEX Biometrics ASA's current Cyclically Adjusted Revenue per Share is €0.76. Overall, IDEX Biometrics ASA has a GF Score™ of 25/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IDEX Biometrics ASA's Cyclically Adjusted Revenue per Share compare to QH and SHOP?
IDEX Biometrics ASA's Cyclically Adjusted Revenue per Share of €0.76 can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Software company?
A good Cyclically Adjusted Revenue per Share depends on the Software industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IDEX Biometrics ASA and its competitors. IDEX Biometrics ASA's current Cyclically Adjusted Revenue per Share is €0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEX Biometrics ASA stock overvalued right now?
Based on GuruFocus' analysis, IDEX Biometrics ASA (FRA:I8X) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.05, compared to a current price of €0.75 — trading 1400% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €0.76. IDEX Biometrics ASA's overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For IDEX Biometrics ASA (FRA:I8X), the current Cyclically Adjusted Revenue per Share is €0.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEX Biometrics ASA (FRA:I8X) Overvalued in 2026?

Based on GuruFocus' analysis, IDEX Biometrics ASA stock appears to be overvalued. The current stock price of €0.75 is trading 1400% above its estimated GF Value™ of €0.05. GuruFocus considers IDEX Biometrics ASA to be Significantly Overvalued.

Key valuation signals for FRA:I8X:

  • Cyclically Adjusted Revenue per Share: €0.76
  • GF Value™: €0.05 vs. price of €0.75 (1400% above fair value)
  • GF Score™: 25/100 with 5 warning signs

No single metric tells the full story. See the FRA:I8X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IDEX Biometrics ASA Business Description

Other Exchanges IDXAF:USAIDEX:Norway0MTP:UK
Address Henrik Ibsens gate 90, Oslo, NOR, 0255
IDEX Biometrics ASA develops and manufactures fingerprint biometric cards for access control, digital identity, and payment. Its products use fingerprint biometrics for user authentication and are designed for physical and digital access applications. The company serves banks, enterprises, and public sector organizations through direct sales and channel partners.
25GF Score

Get the complete analysis for FRA:I8X

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75
Price
€0.05
GF Value